Current Cardiology Reports

, Volume 14, Issue 3, pp 350–358 | Cite as

Myocardial Contrast Echocardiography After Myocardial Infarction

Echocardiography (RM Lang, Section Editor)

Abstract

Myocardial contrast echocardiography (MCE) enables direct assessment of the degree and adequacy of microvascular perfusion as well as the presence of wall motion abnormalities. MCE has the following benefits in patients with acute myocardial infarction (MI): 1) rapid and definite diagnosis of acute MI; 2) identification of patients who may benefit from prompt reperfusion therapy; 3) assessment of the efficacy of mechanical or pharmacologic intervention for an open infarct-related artery; 4) estimation of MI size early after reperfusion and residual myocardial viability; 5) identification of being at high risk for post-MI complications and left ventricular remodeling; and 6) assessment of myocardial viability and ischemia prior to hospital discharge. Therefore, MCE is an ideal tool for correct triaging of patients to revascularization and has both prognostic and therapeutic implications in patients with acute MI.

Keywords

Echocardiography Contrast agent Acute myocardial infarction Microcirculation Perfusion Reperfusion Contractile function Coronary intervention Thrombolysis Cardioprotection 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Kaul S, Ito H. Microvasculature in acute myocardial ischemia: part I. Evolving concepts in pathophysiology, diagnosis, and treatment. Circulation. 2004;109:310–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006;3:499–506.PubMedCrossRefGoogle Scholar
  3. 3.
    Senior R. Role of myocardial contrast echocardiography in the clinical evaluation of acute myocardial infarction. Heart. 2003;89:1398–400.PubMedCrossRefGoogle Scholar
  4. 4.
    Hayat SA, Senior R. Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time? Euro Heart J. 2008;29:299–314.CrossRefGoogle Scholar
  5. 5.
    Myocardial KS, Echocardiography C. A wondrous journey! J Am Coll Cardiol Img. 2010;3:212–8.Google Scholar
  6. 6.
    Pope JH, Selker HP. Acute coronary syndromes in the emergency department: diagnostic characteristics, tests and challenges. Cardiol Clin. 2005;23:423–51.PubMedCrossRefGoogle Scholar
  7. 7.
    Forest RS, Shofer FS, Sease KL, Hollander JE. Assessment of the standardized reporting guidelines ECG classification system: the presenting ECG predicts 30 day outcomes. Ann Emerg Med. 2004;44:206–12.PubMedCrossRefGoogle Scholar
  8. 8.
    Pope JH, Ruthazer R, Beshansky JR, et al. The clinical presentation of patients with acute cardiac ischemia in the emergency department :a multicenter controlled clinical trial. J Thromb Thrombolysis. 1998;6:63–74.PubMedCrossRefGoogle Scholar
  9. 9.
    Wei K. Utility contrast echocardiography in the emergency department. J Am Coll Cardiol Img. 2010;3:197–203.Google Scholar
  10. 10.
    Rinkevich D, Kaul S, Wang X-Q, et al. Incremental value of regional perfusion over regional function in patients presenting to the emergency department with suspected cardiac chest pain and non-diagnostic electrocardiographic changes. Eur Heart J. 2005;26:1606–11.PubMedCrossRefGoogle Scholar
  11. 11.
    • Wyrick JJ, Kalvaitis S, McConnell KJ, et al. Cost-efficiency of myocardial contrast echocardiography in patients presenting to the emergency department with chest pain of suspected cardiac origin and a nondiagnostic electrocardiogram. Am J Cardiol. 2008;102:649–52. By excluding cardiac causes in patients presenting to the emergency department with chest pain and a nondiagnostic ECG, MCE can prevent unnecessary admissions and downstream resource utilization, making it a cost-efficient tool in the evaluation of these patients.PubMedCrossRefGoogle Scholar
  12. 12.
    Coggins MP, Sklenar J, Le DE, et al. Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation. 2001;104:2471–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Lafitte S, Higashiyama A, Masugata H, et al. Contrast echocardiography can assess risk area and infarct size during coronary occlusion and reperfusion: experimental validation. J Am Coll Cardiol. 2002;39:1546–54.PubMedCrossRefGoogle Scholar
  14. 14.
    Leong-Poi H, Coggins MP, Sklenar J, et al. Role of collateral blood flow in the apparent disparity between the extent of abnormal wall thickening and perfusion defect size during acute myocardial infarction and demand ischemia. J Am Coll Cardiol. 2005;45:565–72.PubMedCrossRefGoogle Scholar
  15. 15.
    Kloner RA, Jennings RB. The ‘no reflow’ phenomenon after temporary occlusion in the dog. J Clin Invest. 1974;54:1491–508.CrossRefGoogle Scholar
  16. 16.
    Kloner RA, Rude RE, Carlson N, et al. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation. 1980;62:945–52.PubMedGoogle Scholar
  17. 17.
    Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:1699–705.PubMedGoogle Scholar
  18. 18.
    Califf RM, O’Neil W, Stack RS, et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med. 1988;108:658–62.PubMedGoogle Scholar
  19. 19.
    Schofield P, Dawkins KD, Henderson RA, et al. REACT Trial Investigators. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005;353:2758–68.PubMedCrossRefGoogle Scholar
  20. 20.
    Greaves K, Dixon SR, Fejka M, et al. Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction. Heart. 2003;89:139–44.PubMedCrossRefGoogle Scholar
  21. 21.
    Bolognese L, Ducci K, Angioli P, et al. Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes. Circulation. 2004;110:1592–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;9:1993–9.Google Scholar
  23. 23.
    Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570–80.PubMedGoogle Scholar
  24. 24.
    Okamura A, Ito H, Iwakura K, et al. Clinical implications of distal embolization during coronary interventional procedures in patients with acute myocardial infarction: quantitative study with Doppler guidewire. J Am Coll Cardiol: Cardiovasculat Intervention. 2008;1:268–76.Google Scholar
  25. 25.
    Iwakura K, Ito H, Takiuchi S, et al. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation. 1996;94:1269–75.PubMedGoogle Scholar
  26. 26.
    Yamamoto K, Ito H, Iwakura K, et al. Two different coronary blood flow velocity patterns in thrombolysis n myocardial infarction grade 2 in acute myocardial infarction. J Am Coll Cardiol. 2002;40:1755–60.PubMedCrossRefGoogle Scholar
  27. 27.
    • Galiuto L, Garramone B, Scarà A, et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling. Results of the Multicenter AMICI Study. J Am Coll Cardiol. 2008;51:552–9. Among patients with TIMI grade 3 flow, the extent of microvascular damage, detected and quantitated by MCE, is the most powerful independent predictor of LV remodeling after ST-segment elevation MI compared with persistent ST-segment elevation and myocardial blush grade.PubMedCrossRefGoogle Scholar
  28. 28.
    Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223–8.PubMedGoogle Scholar
  29. 29.
    Dijkmans PA, Senior R, Becher HP, et al. Myocardial contrast echocardiography devolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial; perfusion. The evidence so far. J Am Coll Cardiol. 2006;48:2168–77.PubMedCrossRefGoogle Scholar
  30. 30.
    Iwakura K, Okamura A, Koyama Y, et al. Visualization of myocardial hemorrhage with real-time three-dimensional myocardial contrast echocardiography in patients with acute myocardial infarction. J Echocardiogr. doi:10.1007/s12574-011-0087-8.
  31. 31.
    Iwakura K, Ito H, Kawano S, et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol. 2001;38:472–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Sakuma T, Hayashi Y, Sumii K, et al. Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol. 1998;32:890–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999;33:654–60.PubMedCrossRefGoogle Scholar
  34. 34.
    Taniyama Y, Ito H, Iwakura K, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol. 1997;30:1193–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Iwakura K, Ito H, Kawano S, et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J. 2006;27:534–9.PubMedCrossRefGoogle Scholar
  36. 36.
    De Luca G, Dudek D, Sardella G, et al. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur Heart J. 2008;29:3002–10.PubMedCrossRefGoogle Scholar
  37. 37.
    Botker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010;375:727–34.PubMedCrossRefGoogle Scholar
  38. 38.
    Balcells E, Powers ER, Lepper W, et al. Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve. J Am Coll Cardiol. 2003;41:827–33.PubMedCrossRefGoogle Scholar
  39. 39.
    • Iwakura K, Ito H, Okamura A, et al. Comparison of two- versus three-dimensional myocardial contrast echocardiography for assessing subendocardial perfusion abnormality after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2007;100:1502–10. 2D MCE may miss small size of subendocardial defects because of limited echo planes. 3D MCE provides better assessment of myocardial perfusion abnormality.PubMedCrossRefGoogle Scholar
  40. 40.
    • Dwivedi G, Janardhanan R, Hayat SA, et al. Prognostic value of myocardial viability detected by myocardial contrast echocardiography early after acute myocardial infarction. J Am Coll Cardiol. 2007;50:327–34. The extent of residual myocardial viability estimated as contrast defect score a mean of 7 days after acute MI by MCE is a powerful independent predictor of hard cardiac events in patients.PubMedCrossRefGoogle Scholar
  41. 41.
    Olszowska M, Kostkiewicz M, Podolec P, et al. Myocardial viability detected by myocardial contrast echocardiography—Prognostic value in patients after myocardial infarction. Echocardiography. 2010;27:430–43.PubMedCrossRefGoogle Scholar
  42. 42.
    Jayaweera AR, Wei K, Coggins M, et al. Role of capillaries in determining coronary blood flow reserve: new insights using myocardial contrast echocardiography. Am J Physiol. 1999;277:H2363–72.PubMedGoogle Scholar
  43. 43.
    Yano A, Ito H, Iwakura K, et al. Myocardial contrast echocardiography with a new calibration method can estimate myocardial viability in patients with myocardial infarction. J Am Coll Cardiol. 2004;43:1799–806.PubMedCrossRefGoogle Scholar
  44. 44.
    Wei K, Mulvagh SL, Carson L, et al. The safety of Definity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr. 2008;11:1202–6.Google Scholar
  45. 45.
    • Kusnetzky LL, Khalid A, Khumri TM, et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. J Am Coll Cardiol. 2008;51:1704–6. There is no increased mortality risk associated with ultrasonic contrast-enhanced examinations, despite evidence for higher clinical acuity and more comorbid conditions in patients undergoing contrast studies.PubMedCrossRefGoogle Scholar
  46. 46.
    Main ML, Ryan AC, Davis TE, et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol. 2008;102:1742–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Gaibazzi N, Reverberi C, Squeri A. Safety of contrast flash-replenishment stress-echocardiography in 500 patients with a chest pain episode of undetermined origin within the last 5 days. Eur J Echocardiogr. 2009;10:726–32.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Cardiovascular MedicineOkayama University, Graduate School of MedicineOkayamaJapan

Personalised recommendations